Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pharmacomicrobiomics of antidepressant treatment in suspected treatment-resistant depression
NL-OMON50688Phase 4Not yet recruiting
- Sponsor
- Radboud University Medical Center
- Start
- Dec 2021
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial in major depressive disorder (MDD), sponsored by Radboud University Medical Center. Primary endpoints: Change in depression severity, Experienced side effects and 3 more. Planned start Dec 2021; status: not yet recruiting.
02
Conditions
major depressive disorder (MDD)
Beyond the preview
Go deeper on NL-OMON50688.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON50688.